AB Science provides the summary of webcast with Key Opinion Leaders on masitinib Phase 3 results in severe asthma uncontrolled by oral corticosteroids

    NEXT STORY
    Femtech Market value to cross $48.5 billion by 2025: Global Market Insights, Inc.
    PREV STORY
    Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    NewLink Genetics to Participate in Two Upcoming Investor Conferences

    AMES, Iowa, April 06, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical ...

    author_avatar
    NASDAQ Market News

    ARCS Foundation welcomes Mary Jo Whitehouse as Northern California Chapter Co-President

    author_avatar
    NASDAQ Market News

    Special Issue of School Psychology Review Highlights New Approaches to Close the Discipline Gap in US Schools

    author_avatar
    NASDAQ Market News